FolliMax for hair loss | thinning | alopecia
FolliMax is a new formula for the treatment of hair loss and thinning now available in the UK from Medifort. FolliMax utilises refined beta sitosterol combined with other plant sterols shown to have an enhanced synergistic effect.
Beta sitosterol is a phytosterol that comes from plants. It is shown to prevent hair loss by reducing the production of the androgen DHT. It does this by inhibiting the 5-alpha reductase type II enzyme. This enzyme is responsible for the conversion of testosterone to DHT, known to play a significant part in hair loss.
Those who experience the best results are in the early stages of hair loss. Mild to moderate cases will usually see the most success.
L’Oréal launched a product called “Hair Mass” a few years ago. The primary ingredient of this hair loss product was beta sitosterol. Results of their testing showed “significantly positive results”. This is not available any longer. It is not possible for pharmaceutical companies to hold the exclusive rights to beta sitosterol.
There are 60 capsules of FolliMax in one bottle. We recommend two capsules of FolliMax daily, one in the morning and one in the evening with meals.
Please note that beta sitosterol is not recommended for women who are pregnant or breast feeding or anyone who has had an organ or bone marrow transplant. If you are taking any blood thinning agents you should have your INR levels checked as beta sitosterol can affect this.
The added benefit of taking FolliMax is that beta sitosterol has been shown to help reduce cholesterol (it is added to some margarines), can shrink an enlarged prostate gland in men and boost the immune system.
In the USA, the Food and Drug Administration (FDA) has allowed manufacturers of beta sitosterol to include that it reduces the risk of coronary heart disease on the labels of their products.
Various other studies have been conducted on beta sitosterol for the treatment of hair loss including:
Prager, et al. The Journal of Alternative and Complementary Medicine. April, 2002. “Effectiveness of Botanically Derived Inhibitors in the Treatment of Androgenetic Alopecia.”
Cutan, et al. Journal of Cutaneous and Aesthetic Surgery. January 2009. “Serenoa Repens: Does it have any role in the management of Androgenetic Alopecia?”
Martelanc, et al. Journal of Chromatography. August 2009. “Inhibiting inflammation in Human Skin Cells.”